SLC35A5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.692600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.801000E-01
Normal-vs-Stage2
5.224800E-01
Normal-vs-Stage3
3.112000E-02
Normal-vs-Stage4
3.671400E-01
Stage1-vs-Stage2
1.884550E-01
Stage1-vs-Stage3
3.403900E-02
Stage1-vs-Stage4
4.963400E-01
Stage2-vs-Stage3
1.514840E-01
Stage2-vs-Stage4
5.659900E-02
Stage3-vs-Stage4
1.179910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.373200E-01
Normal-vs-AfricanAmerican
6.809200E-01
Normal-vs-Asian
4.738600E-01
Caucasian-vs-AfricanAmerican
7.520800E-01
Caucasian-vs-Asian
4.303000E-01
AfricanAmerican-vs-Asian
5.394400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.181000E-01
Normal-vs-Female
7.588800E-01
Male-vs-Female
8.965900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.310800E-01
Normal-vs-Age(41-60Yrs)
8.333200E-01
Normal-vs-Age(61-80Yrs)
5.013600E-01
Normal-vs-Age(81-100Yrs)
2.470600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.748400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.423000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.893000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.176200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.670000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.271600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.249000E-01
Normal-vs-Daily Drinker
1.725970E-01
Normal-vs-Weekly Drinker
3.508000E-01
Normal-vs-Occasional Drinker
9.669000E-01
Normal-vs-Social Drinker
9.183600E-01
Non Drinker-vs-Daily Drinker
9.982400E-01
Non Drinker-vs-Weekly Drinker
6.974800E-01
Non Drinker-vs-Occasional Drinker
9.952200E-02
Non Drinker-vs-Social Drinker
7.216200E-02
Daily Drinker-vs-Weekly Drinker
6.881000E-01
Daily Drinker-vs-Occasional Drinker
9.897900E-02
Daily Drinker-vs-Social Drinker
7.609600E-02
Weekly Drinker-vs-Occasional Drinker
2.442800E-01
Weekly Drinker-vs-Social Drinker
2.446400E-01
Occasional Drinker-vs-Social Drinker
9.312400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.397970E-01
Normal-vs-Grade 2
2.131900E-02
Normal-vs-Grade 3
3.883800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.010400E-01
Grade 1-vs-Grade 3
3.963400E-01
Grade 1-vs-Grade 4
1.397970E-01
Grade 2-vs-Grade 3
9.966600E-01
Grade 2-vs-Grade 4
2.131900E-02
Grade 3-vs-Grade 4
3.883800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.812000E-01
Normal-vs-NonDiabetic
4.494000E-01
Diabetic-vs-NonDiabetic
6.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.916430E-01
Normal-vs-NoPancreatitis
4.873600E-01
Pancreatitis-vs-NoPancreatitis
6.588400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.384600E-01
Normal-vs-N1
5.655400E-01
N0-vs-N1
9.934000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.690600E-01
Normal-vs-TP53-NonMutant
8.394800E-01
TP53-Mutant-vs-TP53-NonMutant
8.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
